Christopher Mirabelli's Net Worth

$71.3 Million

Who is Christopher Mirabelli?

Christopher Mirabelli has an estimated net worth of $71.3 Million. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, REPLIDYNE INC, CRITICAL THERAPEUTICS INC, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, LEAP THERAPEUTICS, INC., TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, and MEMORY PHARMACEUTICALS CORP.

SEC CIK

Christopher Mirabelli's CIK is 0001262326

Past Insider Trading and Trends

2007 was Christopher Mirabelli's most active year for acquiring shares with 11 total transactions. Christopher Mirabelli's most active month to acquire stocks was the month of January. 2003 was Christopher Mirabelli's most active year for disposing of shares, totalling 9 transactions. Christopher Mirabelli's most active month to dispose stocks was the month of January. 2017 saw Christopher Mirabelli paying a total of $6,436,524.37 for 2,445,841 shares, this is the most they've acquired in one year. In 2016 Christopher Mirabelli cashed out on 14,109,750 shares for a total of $45,700.00, their largest year based on trade value.